{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T01:56:47Z","timestamp":1778637407699,"version":"3.51.4"},"reference-count":54,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2001,9,1]],"date-time":"2001-09-01T00:00:00Z","timestamp":999302400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2001,9]]},"DOI":"10.1006\/excr.2001.5309","type":"journal-article","created":{"date-parts":[[2002,9,16]],"date-time":"2002-09-16T15:46:35Z","timestamp":1032191195000},"page":"54-63","source":"Crossref","is-referenced-by-count":49,"title":["Cytotoxic Effects of Dynorphins through Nonopioid Intracellular Mechanisms"],"prefix":"10.1006","volume":"269","author":[{"given":"Koichi","family":"Tan-No","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gvido","family":"Cebers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatjana","family":"Yakovleva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bee","family":"Hoon Goh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irina","family":"Gileva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyrill","family":"Reznikov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Aguilar-Santelises","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kurt F.","family":"Hauser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Terenius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgy","family":"Bakalkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1006\/excr.2001.5309_RF1","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1126\/science.6128791","article-title":"Nonopiate effects of dynorphin and des-Tyr-dynorphin","volume":"218","author":"Walker","year":"1982","journal-title":"Science"},{"key":"10.1006\/excr.2001.5309_RF2","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/0143-4179(85)90082-4","article-title":"Effects of traumatic injury on dynorphin immunoreactivity in spinal cord","volume":"5","author":"Cox","year":"1985","journal-title":"Neuropeptides"},{"key":"10.1006\/excr.2001.5309_RF3","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/ana.410170414","article-title":"Endogenous opioid immunoreactivity in rat spinal cord following traumatic injury","volume":"17","author":"Faden","year":"1985","journal-title":"Ann. Neurol."},{"key":"10.1006\/excr.2001.5309_RF4","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0167-0115(85)90029-1","article-title":"Increased dynorphin immunoreactivity in spinal cord after traumatic injury","volume":"11","author":"Faden","year":"1985","journal-title":"Regul. Pept."},{"key":"10.1006\/excr.2001.5309_RF5","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/BF02815410","article-title":"Sequential expression of c-fos protooncogene, TNF-alpha, and dynorphin genes in spinal cord following experimental traumatic injury","volume":"23","author":"Yakovlev","year":"1994","journal-title":"Mol. Chem. Neuropathol."},{"key":"10.1006\/excr.2001.5309_RF6","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0304-3959(00)00243-8","article-title":"Extraterritorial neuropathic pain correlates with multisegmental elevation of spinal dynorphin in nerve-injured rats","volume":"86","author":"Malan","year":"2000","journal-title":"Pain"},{"key":"10.1006\/excr.2001.5309_RF7","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1089\/cns.1986.3.295","article-title":"Endogenous opioids in spinal cord injury: A critical evaluation","volume":"3","author":"Long","year":"1986","journal-title":"Cent. Nerv. Syst. Trauma"},{"key":"10.1006\/excr.2001.5309_RF8","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/0165-6147(94)90091-4","article-title":"Non-opioid effects of dynorphins: Possible role of the NMDA receptor","volume":"15","author":"Shukla","year":"1994","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1006\/excr.2001.5309_RF9","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1476-5381.1984.tb10074.x","article-title":"Dynorphin-related peptides cause motor dysfunction in the rat through a non-opiate action","volume":"81","author":"Faden","year":"1984","journal-title":"Br. J. Pharmacol."},{"key":"10.1006\/excr.2001.5309_RF10","first-page":"27","article-title":"Antinociception and paralysis induced by intrathecal dynorphin A","volume":"232","author":"Herman","year":"1985","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1006\/excr.2001.5309_RF11","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0006-8993(89)90982-7","article-title":"Dynorphin A-induced rat hindlimb paralysis and spinal cord injury are not altered by the kappa opioid antagonist nor-binaltorphimine","volume":"497","author":"Long","year":"1989","journal-title":"Brain Res."},{"key":"10.1006\/excr.2001.5309_RF12","first-page":"1167","article-title":"Neurological dysfunction after intrathecal injection of dynorphin A (1-13) in the rat. II. Nonopioid mechanisms mediate loss of motor, sensory and autonomic function","volume":"246","author":"Long","year":"1988","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1006\/excr.2001.5309_RF13","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1006\/exnr.2000.7580","article-title":"Structure\u2013activity analysis of dynorphin A toxicity in spinal cord neurons: Intrinsic neurotoxicity of dynorphin A and its carboxyl-terminal, non-opioid metabolites","volume":"168","author":"Hauser","year":"2001","journal-title":"Exp. Neurol."},{"key":"10.1006\/excr.2001.5309_RF14","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0304-3959(96)03225-3","article-title":"Single intrathecal injections of dynorphin A or des-Tyr-dynorphins produce long-lasting allodynia in rats: Blockade by MK-801 but not naloxone","volume":"68","author":"Vanderah","year":"1996","journal-title":"Pain"},{"key":"10.1006\/excr.2001.5309_RF15","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0304-3959(97)00046-8","article-title":"Spinally administered dynorphin A produces long-lasting allodynia: Involvement of NMDA but not opioid receptors","volume":"72","author":"Laughlin","year":"1997","journal-title":"Pain"},{"key":"10.1006\/excr.2001.5309_RF16","doi-asserted-by":"crossref","first-page":"7074","DOI":"10.1523\/JNEUROSCI.20-18-07074.2000","article-title":"Dynorphin promotes abnormal pain and spinal opioid antinociceptive tolerance","volume":"20","author":"Vanderah","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1006\/excr.2001.5309_RF17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0006-8993(90)90512-A","article-title":"Competitive and non-competitive NMDA antagonists limit dynorphin A-induced rat hindlimb paralysis","volume":"507","author":"Bakshi","year":"1990","journal-title":"Brain Res."},{"key":"10.1006\/excr.2001.5309_RF18","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/0006-8993(92)90090-V","article-title":"Selective potentiation of NMDA-induced activity and release of excitatory amino acids by dynorphin: Possible roles in paralysis and neurotoxicity","volume":"575","author":"Skilling","year":"1992","journal-title":"Brain Res."},{"key":"10.1006\/excr.2001.5309_RF19","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0006-8993(92)90952-6","article-title":"N-Methyl-d-aspartate (NMDA) and opioid receptors mediate dynorphin-induced spinal cord injury: Behavioral and histological studies","volume":"580","author":"Bakshi","year":"1992","journal-title":"Brain Res."},{"key":"10.1006\/excr.2001.5309_RF20","first-page":"358","article-title":"Dynorphin A-induced rat spinal cord injury: Evidence for excitatory amino acid involvement in a pharmacological model of ischemic spinal cord injury","volume":"269","author":"Long","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1006\/excr.2001.5309_RF21","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1113\/jphysiol.1995.sp020541","article-title":"The opioid peptide dynorphin directly blocks NMDA receptor channels in the rat","volume":"482","author":"Chen","year":"1995","journal-title":"J. Physiol."},{"key":"10.1006\/excr.2001.5309_RF22","first-page":"760","article-title":"High-affinity interaction of (des-tyrosyl)dynorphin A(2-17) with NMDA receptors","volume":"291","author":"Tang","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1006\/excr.2001.5309_RF23","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1046\/j.1460-9568.2000.00012.x","article-title":"Dynorphins directly inhibit neuronal nicotinic acetylcholine receptors in PC12 cells","volume":"12","author":"Itoh","year":"2000","journal-title":"Eur. J. Neurosci."},{"key":"10.1006\/excr.2001.5309_RF24","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0014-5793(00)01982-7","article-title":"Arginine-rich peptides are blockers of VR-1 channels with analgesic activity","volume":"481","author":"Planells-Cases","year":"2000","journal-title":"FEBS Lett."},{"key":"10.1006\/excr.2001.5309_RF25","first-page":"359","article-title":"Both dynorphin A(1-17) and [Des-Tyr1]dynorphin A(2-17) inhibit adenylyl cyclase activity in rat caudate putamen","volume":"277","author":"Claye","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1006\/excr.2001.5309_RF26","doi-asserted-by":"crossref","first-page":"6581","DOI":"10.1073\/pnas.96.12.6581","article-title":"Catalysis of peptide dissociation from class II MHC-peptide complexes","volume":"96","author":"Schmitt","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/excr.2001.5309_RF27","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1021\/bi00337a001","article-title":"Preferred conformation, orientation, and accumulation of dynorphin A-(1-13)-tridecapeptide on the surface of neutral lipid membranes","volume":"24","author":"Erne","year":"1985","journal-title":"Biochemistry"},{"key":"10.1006\/excr.2001.5309_RF28","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.1016\/S0021-9258(17)35702-2","article-title":"Competitive binding of dynorphin-(1-13) and beta-endorphin to cerebroside sulfate in solution","volume":"261","author":"Wu","year":"1986","journal-title":"J. Biol. Chem."},{"key":"10.1006\/excr.2001.5309_RF29","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0006-8993(98)00084-5","article-title":"Non-opioid dynorphin binding site on secretory vesicles of a pituitary-derived cell line","volume":"791","author":"Yarygin","year":"1998","journal-title":"Brain Res."},{"key":"10.1006\/excr.2001.5309_RF30","doi-asserted-by":"crossref","first-page":"5346","DOI":"10.1073\/pnas.97.10.5346","article-title":"Behavioral alterations associated with apoptosis and down-regulation of presenilin 1 in the brains of p53-deficient mice","volume":"97","author":"Amson","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/excr.2001.5309_RF31","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0092-8674(95)90165-5","article-title":"Small peptides activate the latent sequence-specific DNA binding function of p53","volume":"83","author":"Hupp","year":"1995","journal-title":"Cell"},{"key":"10.1006\/excr.2001.5309_RF32","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1523\/JNEUROSCI.03-11-02146.1983","article-title":"Regional distribution of dynorphin and neo-endorphin peptides in rat brain, spinal cord, and pituitary","volume":"3","author":"Cone","year":"1983","journal-title":"J. Neurosci."},{"key":"10.1006\/excr.2001.5309_RF33","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1210\/endo-124-5-2392","article-title":"The posttranslational processing of prodynorphin in the rat anterior pituitary","volume":"124","author":"Day","year":"1989","journal-title":"Endocrinology"},{"key":"10.1006\/excr.2001.5309_RF34","doi-asserted-by":"crossref","first-page":"15650","DOI":"10.1074\/jbc.M100482200","article-title":"p53 latency: C-terminal domain prevents binding of p53 core to target but not to nonspecific DNA sequences","volume":"276","author":"Yakovleva","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1006\/excr.2001.5309_RF35","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0167-0115(91)90177-I","article-title":"Expression of preprodynorphin in human small cell lung carcinoma cell lines","volume":"34","author":"Geijer","year":"1991","journal-title":"Regul. Pept."},{"key":"10.1006\/excr.2001.5309_RF36","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1006\/bbrc.1995.2546","article-title":"Characterization of human prodynorphin gene transcripts","volume":"215","author":"Geijer","year":"1995","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1006\/excr.2001.5309_RF37","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3727\/095535491820873191","article-title":"Use of an aqueous soluble tetrazolium\/formazan assay for cell growth assays in culture","volume":"3","author":"Cory","year":"1991","journal-title":"Cancer Commun."},{"key":"10.1006\/excr.2001.5309_RF38","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1096\/fj.99-0890com","article-title":"Clustering of apoptotic cells via bystander killing by peroxides","volume":"14","author":"Reznikov","year":"2000","journal-title":"FASEB J."},{"key":"10.1006\/excr.2001.5309_RF39","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0167-0115(85)90032-1","article-title":"A general procedure for analysis of proenkephalin B derived opioid peptides","volume":"11","author":"Christensson-Nylander","year":"1985","journal-title":"Regul. Pept."},{"key":"10.1006\/excr.2001.5309_RF40","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/nm0697-632","article-title":"Restoration of the growth suppression function of mutant p53 by a synthetic peptide derived from p53 C-terminal domain","volume":"3","author":"Selivanova","year":"1997","journal-title":"Nat. Med."},{"key":"10.1006\/excr.2001.5309_RF41","first-page":"376","article-title":"3H-Naloxone benzoylhydrazone binding in MOR-1-transfected Chinese hamster ovary cells: Evidence for G-protein-dependent antagonist binding","volume":"286","author":"Brown","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1006\/excr.2001.5309_RF42","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1213\/00000539-199808000-00041","article-title":"Partial agonistic activity of naloxone on the opioid receptors expressed from complementary deoxyribonucleic acids in Chinese hamster ovary cells","volume":"87","author":"Fukuda","year":"1998","journal-title":"Anesth. Analg."},{"key":"10.1006\/excr.2001.5309_RF43","doi-asserted-by":"crossref","first-page":"26128","DOI":"10.1074\/jbc.M000345200","article-title":"Oligomerization of mu- and delta-opioid receptors. Generation of novel functional properties","volume":"275","author":"George","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1006\/excr.2001.5309_RF44","first-page":"827","article-title":"Opioid efficacy in a C6 glioma cell line stably expressing the human kappa opioid receptor","volume":"288","author":"Remmers","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1006\/excr.2001.5309_RF45","first-page":"796","article-title":"Antisera against peptides derived from a purified \u03bc-opioid binding protein recognize the protein as well as mu-opioid receptors in brain regions and a cell line","volume":"44","author":"Gioannini","year":"1993","journal-title":"Mol. Pharmacol."},{"key":"10.1006\/excr.2001.5309_RF46","doi-asserted-by":"crossref","first-page":"34924","DOI":"10.1074\/jbc.274.49.34924","article-title":"Conformational and molecular basis for induction of apoptosis by a p53 C-terminal peptide in human cancer cells","volume":"274","author":"Kim","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1006\/excr.2001.5309_RF47","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1399-3011.1991.tb01533.x","article-title":"Amino acid sequence pattern in the regulatory peptides","volume":"38","author":"Bakalkin","year":"1991","journal-title":"Int. J. Pept. Protein Res."},{"key":"10.1006\/excr.2001.5309_RF48","doi-asserted-by":"crossref","first-page":"8256","DOI":"10.1016\/S0021-9258(18)53090-8","article-title":"The binding site for the beta gamma subunits of heterotrimeric G proteins on the beta-adrenergic receptor kinase","volume":"268","author":"Koch","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1006\/excr.2001.5309_RF49","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1126\/science.8259515","article-title":"Modulation of calmodulin plasticity in molecular recognition on the basis of x-ray structures","volume":"262","author":"Meador","year":"1993","journal-title":"Science"},{"key":"10.1006\/excr.2001.5309_RF50","doi-asserted-by":"crossref","first-page":"23851","DOI":"10.1074\/jbc.270.40.23851","article-title":"The regulatory region of calcium\/calmodulin-dependent protein kinase I contains closely associated autoinhibitory and calmodulin-binding domains","volume":"270","author":"Yokokura","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1006\/excr.2001.5309_RF51","doi-asserted-by":"crossref","first-page":"20742","DOI":"10.1074\/jbc.272.33.20742","article-title":"Regulation of protein kinase Cmu by basic peptides and heparin. Putative role of an acidic domain in the activation of the kinase","volume":"272","author":"Gschwendt","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1006\/excr.2001.5309_RF52","doi-asserted-by":"crossref","first-page":"6563","DOI":"10.1128\/MCB.17.11.6563","article-title":"The basic domain of myogenic basic helix-loop-helix (bHLH) proteins is the novel target for direct inhibition by another bHLH protein, Twist","volume":"17","author":"Hamamori","year":"1997","journal-title":"Mol. Cell. Biol."},{"key":"10.1006\/excr.2001.5309_RF53","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/nbt1098-919","article-title":"Peptide modulators of protein\u2013protein interactions in intracellular signaling","volume":"16","author":"Souroujon","year":"1998","journal-title":"Nat. Biotech."},{"key":"10.1006\/excr.2001.5309_RF54","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0092-8674(00)81881-4","article-title":"ER quality control: The cytoplasmic connection","volume":"88","author":"Kopito","year":"1997","journal-title":"Cell"}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482701953091?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482701953091?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T21:49:29Z","timestamp":1680558569000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482701953091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,9]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2001,9]]}},"alternative-id":["S0014482701953091"],"URL":"https:\/\/doi.org\/10.1006\/excr.2001.5309","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2001,9]]}}}